Hodgkins 8

Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage

Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that its Phase 2 “window of opportunity” clinical study of its lead immunotherapy candidate, [...]


Simple Tips to Improve Your Sleep Habits

By Teofilo L. Lee-Chiong Jr., MD Getting Regular Sleep Isn’t Easy. Work demands, worries about finances or family, or a busy schedule can push back [...]


Cancer Survivorship: Anxiety, Stress, and Depression

By Barrie Cassileth, MS, PhD Cancer inevitably stirs up many feelings. It’s normal to become anxious or stressed-out, and many patients and family members face [...]


For a Healthy Heart, #GoRedGetFit

A social media initiative aims to educate and inspire positive change in diet and exercise habits and to promote heart health among multicultural women. By [...]


Getting Started With Yoga

New to yoga? Roll out your mat with confidence by putting these 12 tips into practice. By Jessica Matthews, MS, E-RYT 500 While yoga offers [...]

Head and Neck 2

Keytruda® Approved for Advanced Head and Neck Cancer

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding [...]

Ovarian 8

SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment

A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy [...]

Pancreatic 2

Pancreatic Cancer Cells Find Unique Fuel Sources to Keep from Starving

Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition. This is the [...]


Opdivo® Highly Effective for Some Patients with Lymphomas

The immunotherapeutic agent, Opdivo® (nivolumab), appears to provide long-lasting anti-cancer activity among some patients who have received extensive prior therapy for both B- and T-cell [...]

Prostate 1

Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer

A baseline prostate-specific antigen (PSA) level among men at midlife appears to be highly correlated with the risk of developing lethal prostate cancer within their [...]

« More News Tips & Features